Status:
RECRUITING
Liver Magnetic Resonance Imaging Before Treatment for Rectal Cancer. A Randomised Controlled Trial.
Lead Sponsor:
Vastra Gotaland Region
Conditions:
Rectal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This multicentre randomized controlled trial aims to investigate whether an abbreviated MRI is comparable to a combined single venous phase CT with an additional 3 min equilibrium phase of the liver, ...
Detailed Description
The incidence of rectal cancer in the European Union is approximately 125 000 per year, constituting a third of the total colorectal cancer incidence(1). In Sweden approximately 2000 individuals are d...
Eligibility Criteria
Inclusion
- Adults \>18 years of age
- Endoscopically or clinically diagnosed with (suspected) rectal cancer and considered for further radiological investigation
- Are able to understand trial information and provide oral and written consent
Exclusion
- Patients unable to undergo MRI (causes may include claustrophobia, presence of pacemaker or certain metal components in their body).
- Patients diagnosed with benign disease of the rectum or squamous cell carcinoma
- Patients diagnosed with recurrent rectal cancer
- Patients unable to understand the trial information
Key Trial Info
Start Date :
April 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2029
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05215535
Start Date
April 12 2022
End Date
December 1 2029
Last Update
August 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sahlgrenska University Hospital/Östra
Gothenburg, Sweden